Activation of Rev-erbα attenuates lipopolysaccharide-induced inflammatory reactions in human endometrial stroma cells via suppressing TLR4-regulated NF-κB activation.

Weijie Zhao,Liyuan Cui,Xixi Huang,Songcun Wang,Dajin Li,Liping Li,Yan Sun,Meirong Du
DOI: https://doi.org/10.1093/abbs/gmz078
IF: 3.7
2019-01-01
Acta Biochimica et Biophysica Sinica
Abstract:Perturbation of the circadian rhythm damages the biological characteristics of cells and leads to their dysfunction. Rev-erb alpha, an important gene in the transcription-translation loop of circadian rhythm, is involved in regulating the balance between pro-inflammation and anti-inflammation. The disruption of this balance in human endometrial stroma cells (hESCs) destroys their biological behavior function in maintaining the menstrual cycle and embryonic implantation. Whether pharmacological modulation of Rev-erb alpha affects the inflammation of hESCs remains unclear. In this study, we treated hESCs with lipopolysaccharide (LPS) and found that LPS treatment increased the mRNA levels of pro-inflammatory cytokines, such as interleukin (IL)-1 beta, IL-6, IL-8, IL-18, and TNF alpha, and the secretion of IL-6. SR9009, a Rev-erb alpha agonist, significantly alleviated the LPS-induced production of pro-inflammatory cytokines in hESCs. Meanwhile, knockdown of Rev-erb alpha increased the expressions of IL-1 beta, IL-6, and IL-8, accompanied by an increased mRNA level of the core clock gene Bmal1. Western blot analysis showed that SR9009 inhibited the expression of toll-like receptor 4 (TLR4) and the activation of NF-kappa B induced by LPS. All these findings suggested that pharmacological activation of Rev-erb alpha attenuated the LPS-induced inflammatory response of hESCs by suppressing TLR4-regulated NF-kappa B activation. This study may provide a strategy for preventing inflammation-related endometrial dysfunction and infertility or recurrent implantation failure.
What problem does this paper attempt to address?